ArticleJournal of arrhythmia2026
Quantitative Measurement of Extracellular Vesicle-Sized Particles in Blood Plasma by Laser Diffraction Without an Extraction Process: A Proof-of-Concept Study in Atrial Fibrillation.
Article in Journal of arrhythmia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Extracellular vesicles (EVs) circulate in blood and may serve as disease biomarkers. However, in atrial fibrillation (AF), reliable circulating biomarkers remain limited. Conventional quantification of EVs requires cumbersome extraction procedures that can reduce quantitative accuracy. We investigated whether laser diffraction (LD) enables accurate and reproducible measurement of EV-sized particles in blood plasma without an extraction process. Methods: LD was used to measure particle size and concentration of synthetic liposomes and plasma-derived EV fractions, and the results were compared with nanoparticle tracking analysis (NTA). Particles in plasma were then measured by LD with and without an extraction process, and the impact of dietary conditions was evaluated. Finally, particle concentrations in fasting plasma were compared between 20 controls without AF and 20 patients with AF. Results: For both synthetic liposomes and extracted EV fraction, LD showed quantitative accuracy comparable to NTA, with higher reproducibility. LD-based measurement in plasma without an extraction process produced a size distribution profile similar to that obtained after extraction, whereas the peak particle concentration decreased after extraction, suggesting partial particle loss during processing. Postprandial samples showed contamination by chylomicrons and very-low-density lipoproteins, which shifted the size distribution toward larger particles and interfered with plasma measurement. Using fasting plasma, the concentration of EV-sized particles measured by LD was significantly higher in AF patients than in controls ( Conclusions: LD enables accurate and highly reproducible quantification of EV-sized particles in fasting plasma without an extraction process and may support proof-of-concept biomarker assessment in AF.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.